Orthobiologics Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Orthobiologics Market to 2025 - Global Analysis and Forecasts by Product (Demineralized Bone Matrices, Viscosupplementation Products, Synthetic Orthobiologics, Allografts, Bone Morphogenic Protein and Others); Application (Spinal Fusion, Osteoarthritis & Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery and Others); End User (Hospitals, Orthopedic Clinics, Ambulatory Care Centers and Other End Users)

Report Code: TIPHE100001388 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Orthobiology is a field of science which is engaged in manufacturing the bone and tissue replacement materials for fast healing and quick recovery of injured muscles, broken bones, ligaments and tendons. Orthobiologics is considered as a highly lucrative market due to many growth opportunities.

Orthobiologics are substances, available in the human body for faster healing process of injuries such as, broken bones, injured muscles, and ligaments. The substances are used in higher concentration for accelerating healing process.

Increasing prevalence of spinal disorders, rising cases of sports injuries & road accidents and growing preference of patients for minimally invasive procedures are expected to drive the growth of the market in the coming years. Rise in the emerging nations and government initiatives & funds is expected to offer growth opportunities for the manufacturers operating in the orthobiologics market during the forecast period.

The "Global Orthobiologics Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global orthobiologics market trend. The report aims to provide an overview of global orthobiologics market with detailed market segmentation by product, application, end user and geography. The global orthobiologics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the orthobiologics market.

The global orthobiologics market is segmented on the basis of product, application and end user. Based on product, the orthobiologics market is categorized as, demineralized bone matrices, viscosupplementation products, synthetic orthobiologics, allografts, bone morphogenic protein, and others. On the basis of application, spinal fusion, osteoarthritis & degenerative arthritis, soft-tissue injuries, and others. On the basis of end user, the orthobiologics market is segmented as, hospitals, orthopedic clinics and other end users.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global orthobiologics market based on product, application and end user. It also provides market size and forecast till 2025 for overall orthobiologics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America and Europe dominates the orthobiologics market. The dominance is because of increase in prevalence of arthritis and higher obesity rates that has surged the demand for minimally invasive procedures such as bone grafting and growth factor treatment. However, Asia Pacific is expected to register the highest growth rate during the forecast period due to large geriatric and target patient population, high incidence of osteoarthritis & obesity, increasing government spending on healthcare, and improving healthcare infrastructure.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key orthobiologics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Medtronic, Johnson & Johnson Services, Inc., Stryker, Zimmer Biomet, Globus Medical, Inc., Orthofix International N.V., RTI Surgical, Inc., Kuros Biosciences Ltd., K2M Group Holdings, Inc., and Nuvasive, Inc. among others.

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. ORTHOBIOLOGICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Orthobiologics Market - By Product
3.2.2. Orthobiologics Market - By Application
3.2.3. Orthobiologics Market - By End User
3.2.4. Orthobiologics Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America - PEST Analysis
4. ORTHOBIOLOGICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. ORTHOBIOLOGICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL ORTHOBIOLOGICS MARKET OVERVIEW
5.2. GLOBAL ORTHOBIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
6. ORTHOBIOLOGICS MARKET- GLOBAL REGULATORY SCENARIO
6.1. OVERVIEW
6.2. NORTH AMERICA
6.3. EUROPE
6.4. ASIA PACIFIC
6.5. MIDDLE EAST & AFRICA
6.6. SOUTH AND CENTRAL AMERICA
7. ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - PRODUCT (US$ MN)
7.1. OVERVIEW
7.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. DEMINERALIZED BONE MATRICES MARKET
7.3.1. Overview
7.3.2. Demineralized Bone Matrices Market Revenue Forecasts and Analysis (US$ Mn)
7.4. VISCOSUPPLEMENTATION PRODUCTS MARKET
7.4.1. Overview
7.4.2. Viscosupplementation Products Market Revenue Forecasts and Analysis (US$ Mn)
7.5. SYNTHETIC ORTHOBIOLOGICS MARKET
7.5.1. Overview
7.5.2. Synthetic Orthobiologics Market Revenue Forecasts and Analysis (US$ Mn)
7.6. ALLOGRAFTS MARKET
7.6.1. Overview
7.6.2. Allografts Market Revenue Forecasts and Analysis (US$ Mn)
7.7. BONE MORPHOGENIC PROTEIN MARKET
7.7.1. Overview
7.7.2. Bone Morphogenic Protein Market Revenue Forecasts and Analysis (US$ Mn)
7.8. OTHERS MARKET
7.8.1. Overview
7.8.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - APPLICATION (US$ MN)
8.1. OVERVIEW
8.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. SPINAL FUSION MARKET
8.3.1. Overview
8.3.2. Spinal Fusion Market Revenue Forecasts and Analysis (US$ Mn)
8.4. OSTEOARTHRITIS & DEGENERATIVE ARTHRITIS MARKET
8.4.1. Overview
8.4.2. Osteoarthritis & Degenerative Arthritis Market Revenue Forecasts and Analysis (US$ Mn)
8.5. SOFT-TISSUE INJURIES MARKET
8.5.1. Overview
8.5.2. Soft-Tissue Injuries Market Revenue Forecasts and Analysis (US$ Mn)
8.6. FRACTURE RECOVERY MARKET
8.6.1. Overview
8.6.2. Fracture Recovery Market Revenue Forecasts and Analysis (US$ Mn)
8.7. OTHERS MARKET
8.7.1. Overview
8.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
9. ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - END USER (US$ MN)
9.1. OVERVIEW
9.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. HOSPITALS MARKET
9.3.1. Overview
9.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
9.4. ORTHOPEDIC CLINICS MARKET
9.4.1. Overview
9.4.2. Orthopedic Clinics Market Revenue Forecasts and Analysis (US$ Mn)
9.5. AMBULATORY CARE CENTERS MARKET
9.5.1. Overview
9.5.2. Ambulatory Care Centers Market Revenue Forecasts and Analysis (US$ Mn)
9.6. OTHER END USERS MARKET
9.6.1. Overview
9.6.2. Other End Users Market Revenue Forecasts and Analysis (US$ Mn)
10. NORTH AMERICA ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. NORTH AMERICA ORTHOBIOLOGICS MARKET OVERVIEW
10.2. NORTH AMERICA ORTHOBIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. NORTH AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY PRODUCT (US$ MN)
10.4. NORTH AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY APPLICATION (US$ MN)
10.5. NORTH AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY END USER (US$ MN)
10.6. NORTH AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
10.7. US MARKET OVERVIEW
10.7.1. US Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.7.2. US Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.7.3. US Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.8. CANADA MARKET OVERVIEW
10.8.1. Canada Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.8.2. Canada Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.8.3. Canada Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
10.9. MEXICO MARKET OVERVIEW
10.9.1. Mexico Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
10.9.2. Mexico Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
10.9.3. Mexico Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11. EUROPE ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. EUROPE ORTHOBIOLOGICS MARKET OVERVIEW
11.2. EUROPE ORTHOBIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. EUROPE MARKET REVENUE FORECASTS AND ANALYSIS - BY PRODUCT (US$ MN)
11.4. EUROPE MARKET REVENUE FORECASTS AND ANALYSIS - BY APPLICATION (US$ MN)
11.5. EUROPE MARKET REVENUE FORECASTS AND ANALYSIS - BY END USER (US$ MN)
11.6. EUROPE MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
11.7. UK MARKET OVERVIEW
11.7.1. UK Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.7.2. UK Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.7.3. UK Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.8. GERMANY MARKET OVERVIEW
11.8.1. Germany Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.8.2. Germany Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.8.3. Germany Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
11.9. FRANCE MARKET OVERVIEW
11.9.1. France Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
11.9.2. France Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
11.9.3. France Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12. ASIA PACIFIC ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. ASIA PACIFIC ORTHOBIOLOGICS MARKET OVERVIEW
12.2. ASIA PACIFIC ORTHOBIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. ASIA PACIFIC MARKET REVENUE FORECASTS AND ANALYSIS - BY PRODUCT (US$ MN)
12.4. ASIA PACIFIC MARKET REVENUE FORECASTS AND ANALYSIS - BY APPLICATION (US$ MN)
12.5. ASIA PACIFIC MARKET REVENUE FORECASTS AND ANALYSIS - BY END USER (US$ MN)
12.6. ASIA PACIFIC MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
12.7. JAPAN MARKET OVERVIEW
12.7.1. Japan Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.7.2. Japan Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.7.3. Japan Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.8. CHINA MARKET OVERVIEW
12.8.1. China Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.8.2. China Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.8.3. China Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
12.9. INDIA MARKET OVERVIEW
12.9.1. India Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
12.9.2. India Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
12.9.3. India Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13. MIDDLE EAST AND AFRICA (MEA) ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. MIDDLE EAST AND AFRICA (MEA) ORTHOBIOLOGICS MARKET OVERVIEW
13.2. MIDDLE EAST AND AFRICA (MEA) ORTHOBIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.3. MIDDLE EAST AND AFRICA (MEA) MARKET REVENUE FORECASTS AND ANALYSIS - BY PRODUCT (US$ MN)
13.4. MIDDLE EAST AND AFRICA (MEA) MARKET REVENUE FORECASTS AND ANALYSIS - BY APPLICATION (US$ MN)
13.5. MIDDLE EAST AND AFRICA (MEA) MARKET REVENUE FORECASTS AND ANALYSIS - BY END USER (US$ MN)
13.6. MIDDLE EAST AND AFRICA (MEA) MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
13.7. SOUTH AFRICA MARKET OVERVIEW
13.7.1. South Africa Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.7.2. South Africa Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.7.3. South Africa Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.8. SAUDI ARABIA MARKET OVERVIEW
13.8.1. Saudi Arabia Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.8.2. Saudi Arabia Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.8.3. Saudi Arabia Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
13.9. UAE MARKET OVERVIEW
13.9.1. UAE Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
13.9.2. UAE Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
13.9.3. UAE Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
?
14. SOUTH AND CENTRAL AMERICA ORTHOBIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. SOUTH AND CENTRAL AMERICA ORTHOBIOLOGICS MARKET OVERVIEW
14.2. SOUTH AND CENTRAL AMERICA ORTHOBIOLOGICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.3. SOUTH AND CENTRAL AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY PRODUCT (US$ MN)
14.4. SOUTH AND CENTRAL AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY APPLICATION (US$ MN)
14.5. SOUTH AND CENTRAL AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY END USER (US$ MN)
14.6. SOUTH AND CENTRAL AMERICA MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
14.7. BRAZIL MARKET OVERVIEW
14.7.1. Brazil Orthobiologics Market Revenue Forecasts and Analysis-By Product (US$ Mn)
14.7.2. Brazil Orthobiologics Market Revenue Forecasts and Analysis-By Application (US$ Mn)
14.7.3. Brazil Orthobiologics Market Revenue Forecasts and Analysis-By End User (US$ Mn)
15. INDUSTRY LANDSCAPE
15.1. ORGANIC GROWTH STRATEGIES
15.1.1. New Product Launches
15.1.2. Marketing & Promotional Activities
15.2. INORGANIC GROWTH STRATEGIES
15.2.1. Partnerships, Collaborations, and Joint Ventures
15.2.2. Mergers & Acquisitions
16. ORTHOBIOLOGICS MARKET, KEY COMPANY PROFILES
16.1. MEDTRONIC
16.1.1. Key Facts
16.1.2. Business Description
16.1.3. Financial Overview
16.1.4. Product Portfolio
16.1.5. Product Pipeline
16.1.6. SWOT Analysis
16.1.7. Key Developments
16.2. JOHNSON & JOHNSON SERVICES, INC.
16.2.1. Key Facts
16.2.2. Business Description
16.2.3. Financial Overview
16.2.4. Product Portfolio
16.2.5. Product Pipeline
16.2.6. SWOT Analysis
16.2.7. Key Developments
16.3. STRYKER
16.3.1. Key Facts
16.3.2. Business Description
16.3.3. Financial Overview
16.3.4. Product Portfolio
16.3.5. Product Pipeline
16.3.6. SWOT Analysis
16.3.7. Key Developments
16.4. ZIMMER BIOMET
16.4.1. Key Facts
16.4.2. Business Description
16.4.3. Financial Overview
16.4.4. Product Portfolio
16.4.5. Product Pipeline
16.4.6. SWOT Analysis
16.4.7. Key Developments
16.5. GLOBUS MEDICAL, INC.
16.5.1. Key Facts
16.5.2. Business Description
16.5.3. Financial Overview
16.5.4. Product Portfolio
16.5.5. Product Pipeline
16.5.6. SWOT Analysis
16.5.7. Key Developments
16.6. ORTHOFIX INTERNATIONAL N.V.
16.6.1. Key Facts
16.6.2. Business Description
16.6.3. Financial Overview
16.6.4. Product Portfolio
16.6.5. Product Pipeline
16.6.6. SWOT Analysis
16.6.7. Key Developments
16.7. RTI SURGICAL, INC.
16.7.1. Key Facts
16.7.2. Business Description
16.7.3. Financial Overview
16.7.4. Product Portfolio
16.7.5. Product Pipeline
16.7.6. SWOT Analysis
16.7.7. Key Developments
16.8. KUROS BIOSCIENCES LTD.
16.8.1. Key Facts
16.8.2. Business Description
16.8.3. Financial Overview
16.8.4. Product Portfolio
16.8.5. Product Pipeline
16.8.6. SWOT Analysis
16.8.7. Key Developments
16.9. K2M GROUP HOLDINGS, INC.
16.9.1. Key Facts
16.9.2. Business Description
16.9.3. Financial Overview
16.9.4. Product Portfolio
16.9.5. Product Pipeline
16.9.6. SWOT Analysis
16.9.7. Key Developments
16.10. NUVASIVE, INC.
16.10.1. Key Facts
16.10.2. Business Description
16.10.3. Financial Overview
16.10.4. Product Portfolio
16.10.5. Product Pipeline
16.10.6. SWOT Analysis
16.10.7. Key Developments
17. APPENDIX
17.1. ABOUT THE INSIGHT PARTNERS
17.2. GLOSSARY OF TERMS
17.3. RESEARCH METHODOLOGY
The List of Companies

1. Medtronic
2. Johnson & Johnson Services, Inc.
3. Stryker
4. Zimmer Biomet
5. Globus Medical, Inc.
6. Orthofix International N.V.
7. RTI Surgical, Inc.
8. Kuros Biosciences Ltd.
9. K2M Group Holdings, Inc.
10. Nuvasive, Inc.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book